BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30339750)

  • 1. Binding Residence Time through Scaled Molecular Dynamics: A Prospective Application to hDAAO Inhibitors.
    Bernetti M; Rosini E; Mollica L; Masetti M; Pollegioni L; Recanatini M; Cavalli A
    J Chem Inf Model; 2018 Nov; 58(11):2255-2265. PubMed ID: 30339750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
    Lange JH; Venhorst J; van Dongen MJ; Frankena J; Bassissi F; de Bruin NM; den Besten C; de Beer SB; Oostenbrink C; Markova N; Kruse CG
    Eur J Med Chem; 2011 Oct; 46(10):4808-19. PubMed ID: 21880399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of inhibitor-binding pockets of d-amino acid oxidase using docking simulation and N-sulfanylethylanilide-based labeling technology.
    Kohiki T; Kato Y; Nishikawa Y; Yorita K; Sagawa I; Denda M; Inokuma T; Shigenaga A; Fukui K; Otaka A
    Org Biomol Chem; 2017 Jun; 15(25):5289-5297. PubMed ID: 28509930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Dynamics Simulations and Kinetic Measurements to Estimate and Predict Protein-Ligand Residence Times.
    Mollica L; Theret I; Antoine M; Perron-Sierra F; Charton Y; Fourquez JM; Wierzbicki M; Boutin JA; Ferry G; Decherchi S; Bottegoni G; Ducrot P; Cavalli A
    J Med Chem; 2016 Aug; 59(15):7167-76. PubMed ID: 27391254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human DAAO variants potentially related to an increased risk of schizophrenia.
    Caldinelli L; Sacchi S; Molla G; Nardini M; Pollegioni L
    Biochim Biophys Acta; 2013 Mar; 1832(3):400-10. PubMed ID: 23219954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
    Hopkins SC; Heffernan ML; Saraswat LD; Bowen CA; Melnick L; Hardy LW; Orsini MA; Allen MS; Koch P; Spear KL; Foglesong RJ; Soukri M; Chytil M; Fang QK; Jones SW; Varney MA; Panatier A; Oliet SH; Pollegioni L; Piubelli L; Molla G; Nardini M; Large TH
    J Med Chem; 2013 May; 56(9):3710-24. PubMed ID: 23631755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment.
    Caldinelli L; Molla G; Bracci L; Lelli B; Pileri S; Cappelletti P; Sacchi S; Pollegioni L
    Protein Sci; 2010 Aug; 19(8):1500-12. PubMed ID: 20521334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel human D-amino acid oxidase inhibitors stabilize an active-site lid-open conformation.
    Terry-Lorenzo RT; Chun LE; Brown SP; Heffernan ML; Fang QK; Orsini MA; Pollegioni L; Hardy LW; Spear KL; Large TH
    Biosci Rep; 2014 Aug; 34(4):. PubMed ID: 25001371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating levels of the neuromodulator d-serine in human brain: structural insight into pLG72 and d-amino acid oxidase interaction.
    Birolo L; Sacchi S; Smaldone G; Molla G; Leo G; Caldinelli L; Pirone L; Eliometri P; Di Gaetano S; Orefice I; Pedone E; Pucci P; Pollegioni L
    FEBS J; 2016 Sep; 283(18):3353-70. PubMed ID: 27400736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput Screening Strategy Identifies Allosteric, Covalent Human D-Amino Acid Oxidase Inhibitor.
    Terry-Lorenzo RT; Masuda K; Sugao K; Fang QK; Orsini MA; Sacchi S; Pollegioni L
    J Biomol Screen; 2015 Dec; 20(10):1218-31. PubMed ID: 26296926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility.
    Sacchi S; Bernasconi M; Martineau M; Mothet JP; Ruzzene M; Pilone MS; Pollegioni L; Molla G
    J Biol Chem; 2008 Aug; 283(32):22244-56. PubMed ID: 18544534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
    Ferraris DV; Tsukamoto T
    Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
    Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
    Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.
    Szilágyi B; Skok Ž; Rácz A; Frlan R; Ferenczy GG; Ilaš J; Keserű GM
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1693-1698. PubMed ID: 29699925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Residence Time and Drug Unbinding Pathway through Scaled Molecular Dynamics.
    Schuetz DA; Bernetti M; Bertazzo M; Musil D; Eggenweiler HM; Recanatini M; Masetti M; Ecker GF; Cavalli A
    J Chem Inf Model; 2019 Jan; 59(1):535-549. PubMed ID: 30500211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.
    Szilágyi B; Kovács P; Ferenczy GG; Rácz A; Németh K; Visy J; Szabó P; Ilas J; Balogh GT; Monostory K; Vincze I; Tábi T; Szökő É; Keserű GM
    Bioorg Med Chem; 2018 May; 26(8):1579-1587. PubMed ID: 29472125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating Drug-Target Residence Time in Kinases through Enhanced Sampling Simulations.
    Gobbo D; Piretti V; Di Martino RMC; Tripathi SK; Giabbai B; Storici P; Demitri N; Girotto S; Decherchi S; Cavalli A
    J Chem Theory Comput; 2019 Aug; 15(8):4646-4659. PubMed ID: 31246463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationships in human d-amino acid oxidase variants corresponding to known SNPs.
    Cappelletti P; Piubelli L; Murtas G; Caldinelli L; Valentino M; Molla G; Pollegioni L; Sacchi S
    Biochim Biophys Acta; 2015 Sep; 1854(9):1150-9. PubMed ID: 25701391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.